Clascoterone Cream (Winlevi) for Acne
Date: December 27, 2021
Issue #:
1640Summary:
The FDA has approvedWinlevi (Sun), a 1% cream
formulation of the androgen receptor inhibitor
clascoterone, for treatment of acne vulgaris in
patients ≥12 years old. It is the first topical androgen
receptor inhibitor to be approved by the FDA.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Acanya Acne Aczone Adapalene Aklief Altreno Amzeeq Antibacterials Arazlo Atralin Avita Azelaic acid Azelex Benzaclin Benzamycin Benzoyl peroxide Biacna clascoterone Cleocin Clindamycin Clindoxy Dalacin Dapsone Source Type: research